Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161486 · ClinicalTrials.gov registry record · Phase 1
The Effects of Testosterone on Prostate Tissue (ACYP-1)
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00161486: Completed Phase 1 study, sponsored by University of Washington.
NCT00161486 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 13 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00161486, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
Interventions
- DRUG Acyline
- DRUG Testosterone gel
- DRUG Placebo acyline
- DRUG Placebo Testosterone gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2004-07 |
| Est. Completion | 2004-11 |
| Phase | Phase 1 |
What the finished NCT00161486 record still lists
NCT00161486 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 4 interventions - of which Acyline is the first listed.
NCT00161486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00161486 about?
NCT00161486 is a clinical study titled "The Effects of Testosterone on Prostate Tissue (ACYP-1)". The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.
What is the current status of trial NCT00161486?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2004-07. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00161486?
The interventions under investigation include: Acyline (DRUG), Testosterone gel (DRUG), Placebo acyline (DRUG), Placebo Testosterone gel (DRUG).
Who is sponsoring clinical trial NCT00161486?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00161486's enrollment target sits among peer trials
13 1847th of 2000 higher than 149 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia